Health Canada places restrictions on Allergan's fibroid treatment Esmya

Canada's health regulator on Friday said it was restricting the use of Allergan Plc's uterine fibroid treatment Esmya after discovering a risk of serious liver injury from the drug.

from Reuters: Health News https://reut.rs/2VNcKwe
via IFTTT